UNIGE document Scientific Article
previous document  unige:33358  next document
add to browser collection
Title

Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology

Authors
Bourigault, Marie-Laure
Vacher, Rachel
Rose, Stéphanie
Quesniaux, Valerie Fj
Published in American Journal of Clinical and Experimental Immunology. 2013, vol. 2, no. 1, p. 124-34
Abstract Tuberculosis (TB) is a major health problem requiring sustained immunity to inhibit Mycobacterium tuberculosis growth and appropriate antimicrobial therapy to prevent dissemination and drug resistance. Cell-mediated immune responses to M. tuberculosis involve the activation of cytokines such as Tumor Necrosis Factor (TNF) which is critical for granuloma formation and host resistance against TB. TNF inhibition, used as therapy for the treatment of inflammatory diseases, disrupts granuloma allowing replication of mycobacteria which may increase the efficacy of TB chemotherapy. To test this hypothesis mice infected with M. tuberculosis were treated with isoniazid (INH) and rifampicin (RMP) in the presence or absence of Enbrel, a soluble TNF receptor antagonist during three phases of M. tuberculosis infection. Inhibition of TNF with Enbrel augmented the efficacy of TB chemotherapy as shown by enhanced mycobacterial clearance from the lung of acute and established infection as well as in chronically infected mice. Furthermore, TNF inhibition significantly reduced lung pathology as compared to TB chemotherapy alone. Therefore, the experimental data suggest that TB chemotherapy may be more effective in the presence of a TNF inhibitor, which may be relevant to eradicate mycobacteria during chronic M. tuberculosis infection or reactivation.
Identifiers
PMID: 23885330
Full text
Article (Published version) (1 MB) - public document Free access
Structures
Research group Rôles des cytokines de la famille du TNF dans les infections mycobactériennes (500)
Projects FNS: 3200A0-118196
ligue Pulmonaire Genevoise, Le Studium Orleans, France
Citation
(ISO format)
BOURIGAULT, Marie-Laure et al. Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology. In: American Journal of Clinical and Experimental Immunology, 2013, vol. 2, n° 1, p. 124-34. https://archive-ouverte.unige.ch/unige:33358

279 hits

151 downloads

Update

Deposited on : 2014-01-16

Export document
Format :
Citation style :